Pharmaceutical

Listen: Illumina’s boardroom intrigue, the next big Alz...

Apr 7, 2023

Is Illumina the Disney of biotech? Does the Texas two-step work after all? And c...

STAT+: FDA withdraws approval of controversial drug to prevent preterm births

STAT+: FDA withdraws approval of controversial drug to ...

Apr 7, 2023

After a years-long controversy, the FDA has ordered the immediate withdrawal of ...

STAT+: To make immunotherapy safe for brain tumors, researchers will have to tackle new risks

STAT+: To make immunotherapy safe for brain tumors, res...

Apr 7, 2023

CAR-T immunotherapy has been looked to as a possible breakthrough for brain canc...

STAT+: Pharmalittle: Weight-loss drug ads pose new oversight challenge; will the new Bayer CEO split the company?

STAT+: Pharmalittle: Weight-loss drug ads pose new over...

Apr 7, 2023

Splashy ads promoting the Wegovy and Ozempic weight-loss treatments risk exploit...

STAT+: With Apollo Endosurgery acquisition, Boston Scientific dives into the obesity treatment market

STAT+: With Apollo Endosurgery acquisition, Boston Scie...

Apr 7, 2023

Boston Scientific will have a significant learning curve as it looks to become a...

Where is the White House’s new pandemic response office?

Where is the White House’s new pandemic response office?

Apr 7, 2023

Congress told the White House in December to create a new, permanent office to c...

Opinion: In a world of synthetic biology, publishing virus DNA sequences may mean perishing

Opinion: In a world of synthetic biology, publishing vi...

Apr 7, 2023

It is hard to imagine that a species that could figure out how to write, print a...

STAT+: With weight loss drug ads, telehealth companies wade into a regulatory gray area

STAT+: With weight loss drug ads, telehealth companies ...

Apr 7, 2023

“In the old days, drug companies advertised prescription drugs, doctors prescrib...

Federal judge suspends FDA approval of abortion pill

Federal judge suspends FDA approval of abortion pill

Apr 7, 2023

A federal judge has suspended the FDA's approval of the abortion pill mifepristone.

STAT+: Digital health pioneer Pear Therapeutics files for bankruptcy

STAT+: Digital health pioneer Pear Therapeutics files f...

Apr 7, 2023

The road has run out for Pear Therapeutics: the pioneering digital therapeutics ...

STAT+: Pharmalittle: Genentech finds no evidence of fraud in paper by former top exec; FDA withdraws approval for premature-birth drug

STAT+: Pharmalittle: Genentech finds no evidence of fra...

Apr 7, 2023

Genentech said a review of allegations concerning a paper co-authored by Marc Te...

STAT+: Liver disease researchers are hoping AI can improve their trial design

STAT+: Liver disease researchers are hoping AI can impr...

Apr 7, 2023

Researchers hope that tools like ChatGPT could be useful in helping find targets...

STAT+: Wall Street embraces health insurers after scoring Medicare Advantage payment win

STAT+: Wall Street embraces health insurers after scori...

Apr 7, 2023

Wall Street is embracing health insurers after they scored a big win for Medicar...

STAT+: A new AI tool aims to help surgeons quickly analyze brain tumor mutations during surgery

STAT+: A new AI tool aims to help surgeons quickly anal...

Apr 7, 2023

A new AI tool called DeepGlioma aims to give surgeons a real-time way to test br...

Opinion: I declined to share my medical data with advertisers at my doctor’s office. One company claimed otherwise

Opinion: I declined to share my medical data with adver...

Apr 7, 2023

Sharing health data with advertisers should be banned.

Verismo Therapeutics’ SynKIR-110 receives fast track designation from FDA

Verismo Therapeutics’ SynKIR-110 receives fast track de...

Apr 6, 2023

SynKIR-110 is an investigational drug to treat mesothelin-expressing mesotheliom...